BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20099364)

  • 21. Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions.
    Ashton E; Raunig D; Ng C; Kelcz F; McShane T; Evelhoch J
    J Magn Reson Imaging; 2008 Sep; 28(3):791-6. PubMed ID: 18777526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
    Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
    Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
    Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
    Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tracer kinetic analysis of dynamic contrast-enhanced MRI and CT bladder cancer data: A preliminary comparison to assess the magnitude of water exchange effects.
    Bains LJ; McGrath DM; Naish JH; Cheung S; Watson Y; Taylor MB; Logue JP; Parker GJ; Waterton JC; Buckley DL
    Magn Reson Med; 2010 Aug; 64(2):595-603. PubMed ID: 20665802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
    Wechsel HW; Petri E; Bichler KH; Feil G
    Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timing bolus dynamic contrast-enhanced (DCE) MRI assessment of hepatic perfusion: Initial experience.
    Baxter S; Wang ZJ; Joe BN; Qayyum A; Taouli B; Yeh BM
    J Magn Reson Imaging; 2009 Jun; 29(6):1317-22. PubMed ID: 19472388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal cell carcinoma: Children's Hospital Boston experience.
    Estrada CR; Suthar AM; Eaton SH; Cilento BG
    Urology; 2005 Dec; 66(6):1296-300. PubMed ID: 16360460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limitations of the permeability-limited compartment model in estimating vascular permeability and interstitial volume fraction in DCE-MRI.
    Carreira GC; Gemeinhardt O; Gorenflo R; Beyersdorff D; Franiel T; Plendl J; Lüdemann L
    Magn Reson Imaging; 2011 Jun; 29(5):639-49. PubMed ID: 21546193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
    Faccioli N; Marzola P; Boschi F; Sbarbati A; D'Onofrio M; Pozzi Mucelli R
    Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characterization and staging of renal tumors: significance of MRI diagnostics].
    Kalinka A; Gerlach A; Arlart IP; Günes N; Hauser TK; Würstlin S; Bosse A
    Rofo; 2006 Mar; 178(3):298-305. PubMed ID: 16508837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative estimation of dynamic contrast enhanced MRI parameters in rat brain gliomas using a dual surface coil system.
    Pickup S; Chawla S; Poptani H
    Acad Radiol; 2009 Mar; 16(3):341-50. PubMed ID: 19201363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiofrequency ablation of renal tumors in the solitary kidney.
    Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
    Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling.
    Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
    Magn Reson Imaging; 2008 Feb; 26(2):160-70. PubMed ID: 17692490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
    Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
    Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging measurements of vascular permeability and extracellular volume fraction of breast tumors by dynamic Gd-DTPA-enhanced relaxometry.
    Vincensini D; Dedieu V; Eliat PA; Vincent C; Bailly C; de Certaines J; Joffre F
    Magn Reson Imaging; 2007 Apr; 25(3):293-302. PubMed ID: 17371717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer.
    de Lussanet QG; Backes WH; Griffioen AW; Padhani AR; Baeten CI; van Baardwijk A; Lambin P; Beets GL; van Engelshoven JM; Beets-Tan RG
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1309-15. PubMed ID: 16125874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Error estimation for perfusion parameters obtained using the two-compartment exchange model in dynamic contrast-enhanced MRI: a simulation study.
    Luypaert R; Sourbron S; Makkat S; de Mey J
    Phys Med Biol; 2010 Nov; 55(21):6431-43. PubMed ID: 20952813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.
    Chou CP; Wu MT; Chang HT; Lo YS; Pan HB; Degani H; Furman-Haran E
    Acad Radiol; 2007 May; 14(5):561-73. PubMed ID: 17434070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.